Quecitinib

N/A

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NameQuecitinib
Drug Alias NameQY201QY-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase JAK1Tyrosine-protein kinase 2
Therapy Area/IndicationsPrurigo NodularisPsoriasisPrurigo +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesE-nitiate Biopharmaceuticals (Hangzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesE-nitiate Biopharmaceuticals (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsPrurigo NodularisPsoriasisPrurigo +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A